logo
HIV/hepatitis C virus co-infection: its human face
HIV/hepatitis C virus co-infection: basic, behavioral and clinical research in mental health and drug abuse
Perspectives on HIV/hepatitis C virus co-infection, illicit drug use and mental illness
HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations
Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990–2001
Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use disorders
Hepatitis C virus infection, substance use and mental illness among homeless youth: a review
Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention
Health disparities among African-American and Hispanic drug injectors – HIV, AIDS, hepatitis B virus and hepatitis C virus: a review
A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection
The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects
The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease
Neuropsychological test performance in patients co-infected with hepatitis C virus and HIV
Relative impact of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in chronic hepatitis C infection
Neurological and neuropsychiatric syndromes associated with liver disease
Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans
Integrated hepatitis C virus treatment: addressing comorbid substance use disorders and HIV infection
Effects of hepatic function and hepatitis C virus on the nervous system assessment of advanced-stage HIV-infected individuals
Extrahepatic immunological complications of hepatitis C virus infection
Hepatitis C virus infection and mixed cryoglobulinaemia vasculitis: a review of neurological complications
Peripheral neuropathies associated with HIV and hepatitis C co-infection: a review
Emerging evidence of hepatitis C virus neuroinvasion
Differential display analysis of gene expression in brains from hepatitis C-infected patients
Hepatitis C virus populations in the plasma, peripheral blood mononuclear cells and cerebrospinal fluid of HIV/hepatitis C virus-co-infected patients
Treatment of hepatitis C virus in HIV patients: a review
Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study
A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users
Hepatitis C virus treatment decision-making in the context of HIV co-infection: the role of medical, behavioral and mental health factors in assessing treatment readiness
HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention
Provider assessment of eligibility for hepatitis C treatment in HIV-infected homeless and marginally housed persons
Supported medical care: a multi-faceted approach to helping HIV/hepatitis C virus co-infected adults with serious mental illness
Integration of pharmacotherapy for opioid addiction into HIV primary care for HIV/hepatitis C virus-co-infected patients
Integrating care for patients with infectious, psychiatric, and substance use disorders: concepts and approaches